Microwave hyperthermia enhances radiosensitization by decreasing DNA repair efficiency and inducing oxidative stress in PC3 prostatic adenocarcinoma cells

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):1–14. doi: 10.3322/caac.21660.
   Web of Science ®Google Scholar
• Teo MY, Rathkopf DE, Kantoff P. Treatment of advanced prostate cancer. Annu Rev Med. 2019;70(1):479–499. doi: 10.1146/annurev-med-051517-011947.
   PubMedGoogle Scholar
• McNevin CS, Baird AM, McDermott R, et al. Diagnostic strategies for treatment selection in advanced prostate cancer. Diagnostics (Basel). 2021;11(2):11. doi: 10.3390/diagnostics11020345.
   Google Scholar
• Jin J. Screening for prostate cancer. JAMA. 2018;319(18):1946. doi: 10.1001/jama.2018.4972.
   PubMed Web of Science ®Google Scholar
• Derks YHW, Löwik DWPM, Sedelaar JPM, et al. PSMA-targeting agents for radio and fluorescence-guided prostate cancer surgery. Theranostics. 2019;9(23):6824–6839. doi: 10.7150/thno.36739.
   PubMed Web of Science ®Google Scholar
• Valle LF, Lehrer EJ, Markovic D, et al. A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer. Eur Urol. 2021;80(3):280–292. doi: 10.1016/j.eururo.2020.11.010.
   PubMed Web of Science ®Google Scholar
• Fay EK, Graff JN. Immunotherapy in prostate cancer. Cancers (Basel). 2020;12(7):12. doi: 10.3390/cancers12071752.
   Web of Science ®Google Scholar
• Abou D, Benabdallah N, Jiang W, et al. Prostate cancer theranostics—an overview. Front Oncol. 2020;10:884. doi: 10.3389/fonc.2020.00884.
   PubMed Web of Science ®Google Scholar
• Nguyen DD, Berlin A, Matthew AG, et al. Sexual function and rehabilitation after radiation therapy for prostate cancer: a review. Int J Impot Res. 2021;33(4):410–417. doi: 10.1038/s41443-020-00389-1.
   PubMed Web of Science ®Google Scholar
• Campodonico F, Ennas M, Zanardi S, et al. Management of prostate cancer with systemic therapy: a prostate cancer unit perspective. Curr Cancer Drug Targets. 2021;21(2):107–116. doi: 10.2174/1568009620666201021163919.
   PubMed Web of Science ®Google Scholar
• Catton C, Lukka H. The evolution of fractionated prostate cancer radiotherapy. Lancet. 2019;394(10196):361–362. doi: 10.1016/S0140-6736(19)31338-8.
   PubMed Web of Science ®Google Scholar
• Sachdev S, Carroll P, Sandler H, et al. Assessment of postprostatectomy radiotherapy as adjuvant or salvage therapy in patients with prostate cancer: a systematic review. JAMA Oncol. 2020;6(11):1793–1800. doi: 10.1001/jamaoncol.2020.2832.
   PubMed Web of Science ®Google Scholar
• Beck M, Ghadjar P, Mehrhof F, et al. Salvage-radiation therapy and regional hyperthermia for biochemically recurrent prostate cancer after radical prostatectomy (results of the planned interim analysis). Cancers (Basel). 2021;13(5):1133. doi: 10.3390/cancers13051133.
   PubMed Web of Science ®Google Scholar
• Datta NR, Jain BM, Mathi Z, et al. Hyperthermia: a potential game-changer in the management of cancers in low-middle-income group countries. Cancers (Basel). 2022;14(2):315. doi: 10.3390/cancers14020315.
   PubMed Web of Science ®Google Scholar
• Datta NR, Marder D, Datta S, et al. Quantification of thermal dose in moderate clinical hyperthermia with radiotherapy: a relook using temperature-time area under the curve (AUC). Int J Hyperthermia. 2021;38(1):296–307.)[doi: 10.1080/02656736.2021.1875060.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hong W, Che S, et al. Outcomes for hyperthermia combined with concurrent radiochemotherapy for patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2020;107(3):499–511. doi: 10.1016/j.ijrobp.2020.03.006.
   PubMed Web of Science ®Google Scholar
• Gani C, Lamprecht U, Ziegler A, et al. Deep regional hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase II trial. Radiother Oncol. 2021;159:155–160. doi: 10.1016/j.radonc.2021.03.011.
   PubMed Web of Science ®Google Scholar
• Hu Y, Li Z, Mi DH, et al. Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysis. J Clin Pharm Ther. 2017;42(2):155–164. doi: 10.1111/jcpt.12498.
   PubMed Web of Science ®Google Scholar
• Dharmaiah S, Zeng J, Rao VS, et al. Clinical and dosimetric evaluation of recurrent breast cancer patients treated with hyperthermia and radiation. Int J Hyperthermia. 2019;36(1):986–992. doi: 10.1080/02656736.2019.1660810.
   PubMed Web of Science ®Google Scholar
• Hurwitz Mark D, Hansen Jorgen L, Prokopios-Davos S, et al. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber cancer institute study 94-153. CANCER. 2011;117(3):510–516. doi: 10.1002/cncr.25619.
   PubMed Web of Science ®Google Scholar
• Maluta S, Dall’Oglio S, Romano M, et al. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study. Int J Hyperthermia. 2007;23(5):451–456. doi: 10.1080/02656730701553260.
   PubMed Web of Science ®Google Scholar
• Le Guevelou J, Chirila ME, Achard V, et al. Combined hyperthermia and radiotherapy for prostate cancer: a systematic review. Int J Hyperthermia. 2022;39(1):547–556. doi: 10.1080/02656736.2022.2053212.
   PubMed Web of Science ®Google Scholar
• Datta NR, Kok HP, Crezee H, et al. Integrating loco-regional hyperthermia into the current oncology practice: SWOT and TOWS analyses. Front Oncol. 2020;10:819. doi: 10.3389/fonc.2020.00819.
   PubMed Web of Science ®Google Scholar
• Wu ZB, Ma SL, Zhu J, et al. An experimental device for heating tumor cell. CN Patent 2015205415415. Filed July 23, 2015; issued December 2, 2015.
   Google Scholar
• Liu P, Wu Y, Xu X, et al. Microwave triggered multifunctional nanoplatform for targeted photothermal-chemotherapy in castration-resistant prostate cancer. Nano Res. 2023;16:9688–9700. doi: 10.1007/s12274-023-5541-1.
   Web of Science ®Google Scholar
• Lin L, Kane N, Kobayashi N, et al. High-dose per fraction radiotherapy induces both antitumor immunity and immunosuppressive responses in prostate tumors. Clin Cancer Res. 2021;27(5):1505–1515. doi: 10.1158/1078-0432.CCR-20-2293.
   PubMed Web of Science ®Google Scholar
• Rajkumar AW, Wang J, Chennupati DV, et al. Optimizing STING activity in prostate cancer pre-clinical models. Int J Radiat Oncol, Biol, Phys. 2021;3S:111. doi: 10.1016/j.ijrobp.2021.07.796.
   Google Scholar
• Peeters H, van Zwol EM, Brancato L, et al. Systematic review of the registered clinical trials for oncological hyperthermia treatment. Int J Hyperthermia. 2022;39(1):806–812. doi: 10.1080/02656736.2022.2076292.
   PubMed Web of Science ®Google Scholar
• Liebl CM, Kutschan S, Dörfler J, et al. Systematic review about complementary medical hyperthermia in oncology. Clin Exp Med. 2022;22(4):519–565. doi: 10.1007/s10238-022-00846-9.
   PubMed Web of Science ®Google Scholar
• Stauffer PR. Evolving technology for thermal therapy of cancer. Int J Hyperthermia. 2005;21(8):731–744. doi: 10.1080/02656730500331868.
   PubMed Web of Science ®Google Scholar
• Walter J, Hader M, Sengedorj A, et al. Broadband microwave spiral applicator (105-125 MHz) for in vitro examinations of hyperthermia-induced tumor cell death forms—first analyses with human breast cancer cells. Int J Hyperthermia. 2023;40(1):2265590. doi: 10.1080/02656736.2023.2265590.
   PubMed Web of Science ®Google Scholar
• Hader M, Streit S, Rosin A, et al. In vitro examinations of cell death induction and the immune phenotype of cancer cells following radiative-based hyperthermia with 915 MHz in combination with radiotherapy. Cells. 2021;10(6):1436. doi: 10.3390/cells10061436.
   PubMed Web of Science ®Google Scholar
• Wang J, Han Y, Li Y, et al. Targeting tumor physical microenvironment for improved radiotherapy. Small Methods. 2022;6(11):e2200570. doi: 10.1002/smtd.202200570.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Ruiz ME, Vanpouille-Box C, Melero I, et al. Immunological mechanisms responsible for radiation-induced abscopal effect. Trends Immunol. 2018;39(8):644–655. doi: 10.1016/j.it.2018.06.001.
   PubMed Web of Science ®Google Scholar
• Ui A, Chiba N, Yasui A. Relationship among DNA double-strand break (DSB), DSB repair, and transcription prevents genome instability and cancer. Cancer Sci. 2020;111(5):1443–1451. doi: 10.1111/cas.14404.
   PubMed Web of Science ®Google Scholar
• Toulany M. Targeting DNA double-strand break repair pathways to improve radiotherapy response. Genes (Basel). 2019;10(1):25. doi: 10.3390/genes10010025.
   PubMed Web of Science ®Google Scholar
• De Ruysscher Dirk N, Gabriele B, Neil G, et al. Radiotherapy toxicity. Nat Rev, Dis Primers. 2019;5(1):13. doi: 10.1038/s41572-019-0064-5.
   PubMedGoogle Scholar
• Shibata A, Jeggo PA. Canonical DNA non-homologous end-joining; capacity versus fidelity. Br J Radiol. 2020;93(1115):20190966. doi: 10.1259/bjr.20190966.
   PubMed Web of Science ®Google Scholar
• Nickoloff JA. Toward greater precision in cancer radiotherapy. Cancer Res. 2021;81(12):3156–3157. doi: 10.1158/0008-5472.CAN-21-0664.
   PubMed Web of Science ®Google Scholar
• Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature. 2005;434(7033):605–611. doi: 10.1038/nature03442.
   PubMed Web of Science ®Google Scholar
• Menolfi D, Zha S. ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion. Cell Biosci. 2020;10(1):8. doi: 10.1186/s13578-020-0376-x.
   PubMed Web of Science ®Google Scholar
• Gomes LR, Menck CFM, Leandro GS. Autophagy roles in the modulation of DNA repair pathways. Int J Mol Sci. 2017;18(11):2351. (11):23. doi: 10.3390/ijms18112351.
   PubMed Web of Science ®Google Scholar
• Gulliver C, Hoffmann R, Baillie GS. Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer. Int J Biochem Cell Biol. 2022;147:106230. doi: 10.1016/j.biocel.2022.106230.
   PubMed Web of Science ®Google Scholar
• Kantidze OL, Velichko AK, Luzhin AV, et al. Synthetically lethal interactions of ATM, ATR, and DNA-PKcs. Trends Cancer. 2018;4(11):755–768. doi: 10.1016/j.trecan.2018.09.007.
   PubMed Web of Science ®Google Scholar
• Ashley AK, Kemp CJ. DNA-PK, ATM, and ATR: PIKKing on p53. Cell Cycle. 2018;17(3):275–276. doi: 10.1080/15384101.2017.1412147.
   PubMed Web of Science ®Google Scholar
• Baek SY, Hwang UW, Suk HY, et al. Hemistepsin a inhibits cell proliferation and induces G0/G1-phase arrest, cellular senescence and apoptosis via the AMPK and p53/p21 signals in human hepatocellular carcinoma. Biomolecules. 2020;10(5):713. doi: 10.3390/biom10050713.
   PubMed Web of Science ®Google Scholar
• Kabakov AE, Yakimova AO. Hypoxia-Induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing. Cancers (Basel). 2021;13(5):1102. doi: 10.3390/cancers13051102.
   PubMed Web of Science ®Google Scholar